Stem cell shot aims to tame multiple sclerosis
Disease control
Ongoing
This early-stage trial tests a single intravenous dose of IMS001, a stem cell product made from human embryonic cells, in 30 adults with multiple sclerosis who have not responded well to standard treatments. The main goal is to see if the treatment is safe and tolerable, while al…
Phase: PHASE1 • Sponsor: ImStem Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC